Overall, EVs from COVID-19 patients expressed TF to a significantly higher extent than EVs from healthy donors (18,925 [10,053–33,028] vs. 1880 [1335–3945] EVs/μL, respectively). The gene discussed is TF; the disease is COVID-19.